Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it open to some biosimilar ...

Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor ...

J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.

Congruence Therapeutics has completed a $39.5m financing round to advance its portfolio of small molecule correctors into the ...

The streamlined framework is part of the UK Government’s plans to ensure the life sciences sector reaches its full potential.

Quintessence's technology is designed to simplify the bio-separation process in CGT manufacturing while reducing production ...

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

Peter Fassler, Director Market Access at Gilead Sciences, highlighted the challenges facing the Netherlands and the rest of ...

Backed by the venture portions of Eli Lily and Eisai, Excalipoint will look to progress the development of its six pipeline ...

Health secretary Wes Streeting is considering expanding the existing schedule to age groups beyond infants, such as teenagers ...